Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
B-cell neoplasia in a developmental framework
G. Klein
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'B-cell neoplasia in a developmental framework'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Virus
100%
Apoptotic Cell Death
100%
Plasma Cells
100%
Development Framework
100%
B-cell Neoplasms
100%
Malignancy
50%
Tumor
50%
B Cells
50%
Plasmacytoma
50%
Induced Activation
50%
C-Myc
50%
Immunodeficiency
50%
Bcl-2 Family Proteins
50%
Genetic Predisposition
50%
Cell Population
50%
Oncogene
50%
B Lymphocytes
50%
Resting State
50%
Immune Surveillance
50%
One-point
50%
Tumor Development
50%
Phenotypic Characteristics
50%
Neoplasia
50%
Immunoblasts
50%
Activated Lymphocytes
50%
Developmental Programming
50%
Lymphoproliferative Disorders
50%
Clonal Expansion
50%
Non-interactive
50%
Growth Potential
50%
Preneoplastic
50%
Immortalization
50%
Biological Framework
50%
Immunoglobulin Loci
50%
Immunoglobulin Genes
50%
Low-grade Lymphoma
50%
Specific Vulnerability
50%
High-grade Lymphoma
50%
Activated State
50%
Immunoglobulin Receptor
50%
Antibody Diversity
50%
Additional mutations
50%
Resting B Cells
50%
Carrier Cells
50%
Immunology and Microbiology
B Cell
100%
Intravenous Immunoglobulin
75%
Immunoglobulin Producing Cell
50%
Virus
50%
Programmed Cell Death
50%
Human Immunodeficiency Virus
25%
Plasmacytoma
25%
Immunodeficiency
25%
Cell Population
25%
Genetic Predisposition
25%
Immunosurveillance
25%
Precursor
25%
Target Cell
25%
Life Cycle
25%
Immunoblast
25%
Proto Oncogene
25%
Oncogene C Myc
25%
Immunoglobulin Gene
25%
Lymphocyte Membrane Immunoglobulin
25%
Antibody Specificity
25%
Lymphocyte
25%
Epstein Barr Virus
25%
Oncogene
25%
In Vitro
25%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Intravenous Immunoglobulin
100%
Myc
50%
Immunoglobulin Producing Cell
50%
Programmed Cell Death
50%
Human Immunodeficiency Virus
25%
Oncogene
25%
Precursor
25%
Oncogene C Myc
25%
Genetic Predisposition
25%
Epstein Barr Virus
25%
Life Cycle
25%
Proto Oncogene
25%
Immunoblast
25%
Target Cell
25%
Immunoglobulin Gene
25%
Immunosurveillance
25%
Antibody Specificity
25%
Lymphocyte
25%
Neuroscience
B Cell
100%
Intravenous Immunoglobulin
75%
Non-Hodgkin Lymphoma
50%
Myc
50%
Immunoglobulin Producing Cell
50%
Programmed Cell Death
50%
In Vitro
25%
Human Immunodeficiency Virus
25%
Immunoblast
25%
Proto Oncogene
25%
Oncogene
25%
Oncogene C Myc
25%
Immunoglobulin Gene
25%
Lymphocyte Membrane Immunoglobulin
25%
Immunoglobulin Receptor
25%
Lymphocyte
25%
Nursing and Health Professions
Neoplasm
100%
Immunoglobulin
100%
Nonhodgkin Lymphoma
50%
Human Immunodeficiency Virus
25%
Immune Deficiency
25%
Target Cell
25%
Lymphoproliferative Disease
25%
Plasmacytoma
25%
Genetic Predisposition
25%
Lymphocyte Membrane Immunoglobulin
25%
Immunoglobulin Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Immunoglobulin
100%
Nonhodgkin Lymphoma
50%
HIV
25%
Immune Deficiency
25%
Genetic Predisposition
25%
Lymphoproliferative Disease
25%
Plasmacytoma
25%
Immunoglobulin Receptor
25%
Lymphocyte Membrane Immunoglobulin
25%